Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration

Ophthalmology

Volumn 123, Issue 5, 2016, Pages 1060-1079

  Schaal, Karen B ^a   Rosenfeld, Philip J ^a   Gregori, Giovanni ^a   Yehoshua, Zohar ^a   Feuer, William J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ALGORITHM; ANATOMIC LANDMARK; ARTICLE; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DATA BASE; DISEASE COURSE; DRUSEN; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; INTERMEDIATE AGE RELATED MACULAR DEGENERATION; LOW LEVEL LASER THERAPY; MEASUREMENT ACCURACY; NEOVASCULARIZATION (PATHOLOGY); NONEXUDATIVE AGE RELATED MACULAR DEGENERATION; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TASK PERFORMANCE; VISUAL ACUITY; VISUAL IMPAIRMENT; BIOASSAY; FACTUAL DATABASE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE IMAGING; MEDLINE; PATHOLOGY; PHYSIOLOGY; RETINA FOVEA; RETINAL DRUSEN; VERY ELDERLY; VISION DISORDERS;

AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; GEOGRAPHIC ATROPHY; HUMANS; OPTICAL IMAGING; PUBMED; RETINAL DRUSEN; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY;

EID: 84959483860     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.01.034     Document Type: Article

References (108)

1. R. Klein, B.E. Klein, and K.L. Linton Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 933 943
2. D. Pascolini, and S.P. Mariotti Global estimates of visual impairment: 2010 Br J Ophthalmol 96 2012 614 618
3. D.S. Friedman, B.J. O'Colmain, B. Munoz, and et al. Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572
4. F.L. Ferris 3rd, C.P. Wilkinson, A. Bird, and et al. Clinical classification of age-related macular degeneration Ophthalmology 120 2013 844 851
5. F.G. Holz, E.C. Strauss, S. Schmitz-Valckenberg, and M. van Lookeren Campagne Geographic atrophy: clinical features and potential therapeutic approaches Ophthalmology 121 2014 1079 1091
6. U. Chakravarthy, S.P. Harding, C.A. Rogers, and et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial Lancet 382 2013 1258 1267
7. P.J. Rosenfeld, H. Shapiro, L. Tuomi, and et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 2011 523 530
8. J.E. Grunwald, E. Daniel, J. Huang, and et al. Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 121 2014 150 161
9. J.E. Grunwald, M. Pistilli, G.S. Ying, and et al. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 122 2015 809 816
10. F.A. Medeiros Biomarkers and surrogate endpoints in glaucoma clinical trials Br J Ophthalmol 99 2015 599 603
11. Z. Yehoshua, P.J. Rosenfeld, and T.A. Albini Current clinical trials in dry AMD and the definition of appropriate clinical outcome measures Semin Ophthalmol 26 2011 167 180
12. K.G. Csaky, E.A. Richman, and F.L. Ferris 3rd Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium Invest Ophthalmol Vis Sci 49 2008 479 489
13. Z. Yehoshua, P.J. Rosenfeld, G. Gregori, and et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography Ophthalmology 118 2011 679 686
14. F.G. Holz, A. Bindewald-Wittich, M. Fleckenstein, and et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration Am J Ophthalmol 143 2007 463 472
15. J.S. Sunness, E. Margalit, D. Srikumaran, and et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials Ophthalmology 114 2007 271 277
16. M. Fleckenstein, S. Schmitz-Valckenberg, C. Adrion, and et al. Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration Invest Ophthalmol Vis Sci 51 2010 3846 3852
17. A.S. Lindblad, P.C. Lloyd, T.E. Clemons, and et al. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26 Arch Ophthalmol 127 2009 1168 1174
18. C. Schutze, C. Ahlers, S. Sacu, and et al. Performance of OCT segmentation procedures to assess morphology and extension in geographic atrophy Acta Ophthalmol 89 2011 235 240
19. B. Diniz, D.C. Rodger, V.R. Chavali, and et al. Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population Eye (Lond) 29 2015 272 279
20. Z. Yehoshua, C.A. de Amorim Garcia Filho, R.P. Nunes, and et al. Comparison of geographic atrophy growth rates using different imaging modalities in the COMPLETE study Ophthalmic Surg Lasers Imaging Retina 46 2015 413 422
21. R. Klein, M.D. Davis, Y.L. Magli, and et al. The Wisconsin age-related maculopathy grading system Ophthalmology 98 1991 1128 1134
22. Age-Related Eye Disease Study Research G The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6 Am J Ophthalmol 132 2001 668 681
23. M.L. Klein, F.L. Ferris 3rd, J. Armstrong, and et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration Ophthalmology 115 2008 1026 1031
24. Complications of Age-related Macular Degeneration Prevention Trial Research G Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial Ophthalmology 115 2008 1474 1479 9 e1-6
25. R. Klein, B.E. Klein, S.C. Jensen, and S.M. Meuer The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 1997 7 21
26. C.C. Klaver, J.J. Assink, R. van Leeuwen, and et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study Invest Ophthalmol Vis Sci 42 2001 2237 2241
27. P. Mitchell, J.J. Wang, S. Foran, and W. Smith Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study Ophthalmology 109 2002 1092 1097
28. A. Pirbhai, T. Sheidow, and P. Hooper Prospective evaluation of digital non-stereo color fundus photography as a screening tool in age-related macular degeneration Am J Ophthalmol 139 2005 455 461
29. J.S. Sunness, N.M. Bressler, Y. Tian, and et al. Measuring geographic atrophy in advanced age-related macular degeneration Invest Ophthalmol Vis Sci 40 1999 1761 1769
30. S. Schmitz-Valckenberg, C.K. Brinkmann, F. Alten, and et al. Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 7640 7646
31. T. Ach, C. Huisingh, G. McGwin Jr., and et al. Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium Invest Ophthalmol Vis Sci 55 2014 4832 4841
32. Z. Ablonczy, D. Higbee, D.M. Anderson, and et al. Lack of correlation between the spatial distribution of A2E and lipofuscin fluorescence in the human retinal pigment epithelium Invest Ophthalmol Vis Sci 54 2013 5535 5542
33. S. Schmitz-Valckenberg, M. Fleckenstein, A.P. Gobel, and et al. Optical coherence tomography and autofluorescence findings in areas with geographic atrophy due to age-related macular degeneration Invest Ophthalmol Vis Sci 52 2011 1 6
34. R.G. Sayegh, C. Simader, U. Scheschy, and et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy Ophthalmology 118 2011 1844 1851
35. C. Simader, R.G. Sayegh, A. Montuoro, and et al. A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy Am J Ophthalmol 158 2014 557 566 e1
36. K. Moussa, J.Y. Lee, S.S. Stinnett, and G.J. Jaffe Spectral domain optical coherence tomography-determined morphologic predictors of age-related macular degeneration-associated geographic atrophy progression Retina 33 2013 1590 1599
37. B.J. Lujan, P.J. Rosenfeld, G. Gregori, and et al. Spectral domain optical coherence tomographic imaging of geographic atrophy Ophthalmic Surg Lasers Imaging 40 2009 96 101
38. S. Bearelly, F.Y. Chau, A. Koreishi, and et al. Spectral domain optical coherence tomography imaging of geographic atrophy margins Ophthalmology 116 2009 1762 1769
39. H.P. Scholl, T. Peto, S. Dandekar, and et al. Inter- and intra-observer variability in grading lesions of age-related maculopathy and macular degeneration Graefes Arch Clin Exp Ophthalmol 241 2003 39 47
40. S. Schmitz-Valckenberg, M. Fleckenstein, A.P. Gobel, and et al. Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy Am J Ophthalmol 146 2008 183 192
41. Z. Yehoshua, C.A. Garcia Filho, F.M. Penha, and et al. Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image Ophthalmic Surg Lasers Imaging Retina 44 2013 127 132
42. Q. Chen, L. de Sisternes, T. Leng, and et al. Semi-automatic geographic atrophy segmentation for SD-OCT images Biomed Opt Express 4 2013 2729 2750
43. W.J. Feuer, Z. Yehoshua, G. Gregori, and et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of Age-Related Eye Disease Study report no. 26 JAMA Ophthalmol 131 2013 110 111
44. Z. Yehoshua, C.A. de Amorim Garcia Filho, R.P. Nunes, and et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study Ophthalmology 121 2014 693 701
45. R.P. Nunes, G. Gregori, Z. Yehoshua, and et al. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina Ophthalmic Surg Lasers Imaging Retina 44 2013 344 359
46. P.F. Stetson, Z. Yehoshua, C.A. Garcia Filho, and et al. OCT minimum intensity as a predictor of geographic atrophy enlargement Invest Ophthalmol Vis Sci 55 2014 792 800
47. A.C. Bird, R.L. Phillips, and G.S. Hageman Geographic atrophy: a histopathological assessment JAMA Ophthalmol 132 2014 338 345
48. A. Domalpally, R.P. Danis, J. White, and et al. Circularity index as a risk factor for progression of geographic atrophy Ophthalmology 120 2013 2666 2671
49. K. Zhang, J.J. Hopkins, J.S. Heier, and et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration Proc Natl Acad Sci U S A 108 2011 6241 6245
50. W.T. Wong, W. Kam, D. Cunningham, and et al. Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial Invest Ophthalmol Vis Sci 51 2010 6131 6139
51. N.L. Mata, J.B. Lichter, R. Vogel, and et al. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration Retina 33 2013 498 507
52. W.T. Wong, S. Dresner, F. Forooghian, and et al. Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial Invest Ophthalmol Vis Sci 54 2013 2941 2950
53. Z. Yehoshua, F. Wang, P.J. Rosenfeld, and et al. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography Ophthalmology 118 2011 2434 2441
54. M.D. Davis, R.E. Gangnon, L.Y. Lee, and et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 Arch Ophthalmol 123 2005 1484 1498
55. J.J. Wang, S. Foran, W. Smith, and P. Mitchell Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort Arch Ophthalmol 121 2003 658 663
56. R. Klein, B.E. Klein, S.C. Tomany, and et al. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 109 2002 1767 1779
57. R. Klein, B.E. Klein, M.D. Knudtson, and et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study Ophthalmology 114 2007 253 262
58. J.J. Wang, E. Rochtchina, A.J. Lee, and et al. Ten-year incidence and progression of age-related maculopathy: the Blue Mountains Eye Study Ophthalmology 114 2007 92 98
59. F.L. Ferris, M.D. Davis, T.E. Clemons, and et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18 Arch Ophthalmol 123 2005 1570 1574
60. J.M. Seddon, S. Sharma, and R.A. Adelman Evaluation of the clinical age-related maculopathy staging system Ophthalmology 113 2006 260 266
61. A.C. Bird, N.M. Bressler, S.B. Bressler, and et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group Surv Ophthalmol 39 1995 367 374
62. N.M. Bressler, B. Munoz, M.G. Maguire, and et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study Arch Ophthalmol 113 1995 301 308
63. J.M. Sparrow, A.J. Dickinson, A.M. Duke, and et al. Seven year follow-up of age-related maculopathy in an elderly British population Eye (Lond) 11 Pt 3 1997 315 324
64. H. Bartlett, and F. Eperjesi Use of fundus imaging in quantification of age-related macular change Surv Ophthalmol 52 2007 655 671
65. R.T. Smith, J.K. Chan, T. Nagasaki, and et al. A method of drusen measurement based on reconstruction of fundus background reflectance Br J Ophthalmol 89 2005 87 91
66. T.R. Friberg, L. Huang, M. Palaiou, and R. Bremer Computerized detection and measurement of drusen in age-related macular degeneration Ophthalmic Surg Lasers Imaging 38 2007 126 134
67. E. Peli, and M. Lahav Drusen measurement from fundus photographs using computer image analysis Ophthalmology 93 1986 1575 1580
68. W.H. Morgan, R.L. Cooper, I.J. Constable, and R.H. Eikelboom Automated extraction and quantification of macular drusen from fundal photographs Aust N Z J Ophthalmol 22 1994 7 12
69. S.A. Zweifel, R.F. Spaide, C.A. Curcio, and et al. Reticular pseudodrusen are subretinal drusenoid deposits Ophthalmology 117 2010 303 312 e1
70. R.F. Spaide Colocalization of pseudodrusen and subretinal drusenoid deposits using high-density en face spectral domain optical coherence tomography Retina 34 2014 2336 2345
71. C.A. Curcio, J.D. Messinger, K.R. Sloan, and et al. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model Retina 33 2013 265 276
72. K.B. Schaal, A.D. Legarreta, G. Gregori, and et al. Widefield en face optical coherence tomography imaging of subretinal drusenoid deposits Ophthalmic Surg Lasers Imaging Retina 46 2015 550 559
73. S.H. Sarks, J.J. Arnold, M.C. Killingsworth, and J.P. Sarks Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study Br J Ophthalmol 83 1999 358 368
74. G. Gregori, F. Wang, P.J. Rosenfeld, and et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration Ophthalmology 118 2011 1373 1379
75. Y. Ouyang, F.M. Heussen, A. Hariri, and et al. Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration Ophthalmology 120 2013 2656 2665
76. Z. Wu, C.D. Luu, L.N. Ayton, and et al. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration Ophthalmology 121 2014 2415 2422
77. Q. Chen, T. Leng, L.L. Zheng, and et al. An improved optical coherence tomography-derived fundus projection image for drusen visualization Retina 34 2014 996 1005
78. F.A. Folgar, E.L. Yuan, M. Sevilla, and et al. Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration Ophthalmology 123 2016 39 50.e1
79. F.G. Schlanitz, S. Sacu, B. Baumann, and et al. Identification of drusen characteristics in age-related macular degeneration by polarization-sensitive optical coherence tomography Am J Ophthalmol 160 2015 335 344.e1
80. G. Gregori, Z. Yehoshua, C.A. Garcia Filho, and et al. Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging Invest Ophthalmol Vis Sci 55 2014 7662 7668
81. Z. Yehoshua, G. Gregori, S.R. Sadda, and et al. Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging Invest Ophthalmol Vis Sci 54 2013 2429 2434
82. B. Diniz, R. Ribeiro, F.M. Heussen, and et al. Drusen measurements comparison by fundus photograph manual delineation versus optical coherence tomography retinal pigment epithelial segmentation automated analysis Retina 34 2014 55 62
83. L. de Sisternes, N. Simon, R. Tibshirani, and et al. Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression Invest Ophthalmol Vis Sci 55 2014 7093 7103
84. N.A. Nathoo, C. Or, M. Young, and et al. Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration Am J Ophthalmol 158 2014 757 761 e1
85. N. Jain, S. Farsiu, A.A. Khanifar, and et al. Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs Invest Ophthalmol Vis Sci 51 2010 4875 4883
86. F.G. Schlanitz, C. Ahlers, S. Sacu, and et al. Performance of drusen detection by spectral-domain optical coherence tomography Invest Ophthalmol Vis Sci 51 2010 6715 6721
87. B. Baumann, E. Gotzinger, M. Pircher, and et al. Segmentation and quantification of retinal lesions in age-related macular degeneration using polarization-sensitive optical coherence tomography J Biomed Opt 15 2010 061704
88. E. Gotzinger, M. Pircher, W. Geitzenauer, and et al. Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography Opt Express 16 2008 16410 16422
89. F.G. Schlanitz, B. Baumann, T. Spalek, and et al. Performance of automated drusen detection by polarization-sensitive optical coherence tomography Invest Ophthalmol Vis Sci 52 2011 4571 4579
90. A.A. Khanifar, A.F. Koreishi, J.A. Izatt, and C.A. Toth Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration Ophthalmology 115 2008 1883 1890
91. M. Stopa, B.A. Bower, E. Davies, and et al. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies Retina 28 2008 298 308
92. E.Y. Chew, T.E. Clemons, E. Agron, and et al. Ten-year follow-up of age-related macular degeneration in the Age-Related Eye Disease Study: AREDS report no. 36 JAMA Ophthalmol 132 2014 272 277
93. C. Cukras, E. Agron, M.L. Klein, and et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28 Ophthalmology 117 2010 489 499
94. M.B. Parodi, G. Virgili, and J.R. Evans Laser treatment of drusen to prevent progression to advanced age-related macular degeneration Cochrane Database Syst Rev 3 2009 CD006537
95. A. Abdelsalam, L. Del Priore, and M.A. Zarbin Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression Surv Ophthalmol 44 1999 1 29
96. R. Margolis, M.D. Ober, and K.B. Freund Disappearance of drusen after rhegmatogenous retinal detachment Retin Cases Brief Rep 4 2010 254 256
97. S. Dithmar, S. Pollithy, and T. Ach Disappearance of central confluent soft drusen following vitrectomy and ILM peeling Eye (Lond) 27 2013 779 781
98. M. Fuseya, Y. Imamura, S. Ishida, and et al. Regression of macular drusen after pars plana vitrectomy in a patient with age-related macular degeneration Retin Cases Brief Rep 1 2007 160 162
99. R. Krishnan, and J. Lochhead Regression of soft drusen and drusenoid pigment epithelial detachment following intravitreal anti-vascular endothelial growth factor therapy Can J Ophthalmol 45 2010 83 84
100. A.I. Jobling, R.H. Guymer, K.A. Vessey, and et al. Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage FASEB J 29 2015 696 710
101. R.H. Guymer, K.H. Brassington, P. Dimitrov, and et al. Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function Clin Experiment Ophthalmol 42 2014 466 479
102. D. Lavinsky, and D. Palanker Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy Retina 35 2015 213 222
103. D. Lavinsky, C. Sramek, J. Wang, and et al. Subvisible retinal laser therapy: titration algorithm and tissue response Retina 34 2014 87 97
104. C.A. de Amorim Garcia Filho, Z. Yehoshua, G. Gregori, and et al. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration Ophthalmic Surg Lasers Imaging Retina 45 2014 18 31
105. C.A. Garcia Filho, Z. Yehoshua, G. Gregori, and et al. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration Ophthalmic Surg Lasers Imaging Retina 45 2014 18 31
106. V.R. Chavali, B. Diniz, J. Huang, and et al. Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population J Clin Med 4 2015 304 317
107. J.W. Busse, M. Bhandari, I. Ferreira-Gonzalez, and et al. Use and interpretation of composite end points in orthopaedic trials J Bone Joint Surg Am 94 Suppl 1 2012 65 69
108. G. Tomlinson, and A.S. Detsky Composite end points in randomized trials: there is no free lunch JAMA 303 2010 267 268